C1711255||Unbiased estimates
C0007806||cerebrospinal fluid
C0169424||β-amyloid 1-42
C0442592||memory clinic
C1257890||population
C0169424||β-amyloid 1-42
C0007806||cerebrospinal fluid
C0007806||cerebrospinal fluid
C0005516||marker
C0002395||Alzheimer's disease
C0002395||Alzheimer's disease
C0026348||Gaussian mixture modeling
C0442592||memory clinic
C1257890||population
C0010362||cross-sectional
C1709709||prospective cohort study
C2349001||subjects
C0234985||subjective cognitive decline
C1270972||mild cognitive impairment
C0002395||Alzheimer's disease
C0497327||dementia
C0497327||dementia
C0002395||Alzheimer's disease
C0497327||Dementia
C0599755||Cohort
C0007806||cerebrospinal fluid
C0169424||β-amyloid 1-42
C0026348||Gaussian mixture modeling
C1515021||subgroups
C0332140||clinical diagnosis
C1446118||apolipoprotein E (APOE) genotype
C0205161||abnormal
C0169424||β-amyloid 1-42
C0002395||Alzheimer's disease
C0497327||dementia
C0205161||abnormal
C0169424||β-amyloid 1-42
C0332140||clinical diagnosis
C0010235||Cox proportional hazards regression
C0205161||abnormal
C0007806||cerebrospinal fluid
C0169424||β-amyloid 1-42
C0011900||diagnostic
C1446118||APOE genotype
C1515021||subgroups
C0001792||elderly
C2349001||subjects
C2349001||subjects
C0332140||clinical diagnosis
C0002395||Alzheimer's disease
C0497327||dementia
C2349001||subjects
C0026348||Mixture modeling
C0025663||method
C0007806||cerebrospinal fluid
C0169424||β-amyloid 1-42
C0002395||Alzheimer's disease
C0332140||clinical diagnosis